Correlation Between Korea Real and Bridge Biotherapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Korea Real and Bridge Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Korea Real and Bridge Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Korea Real Estate and Bridge Biotherapeutics, you can compare the effects of market volatilities on Korea Real and Bridge Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Korea Real with a short position of Bridge Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Korea Real and Bridge Biotherapeutics.

Diversification Opportunities for Korea Real and Bridge Biotherapeutics

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Korea and Bridge is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Korea Real Estate and Bridge Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bridge Biotherapeutics and Korea Real is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Korea Real Estate are associated (or correlated) with Bridge Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bridge Biotherapeutics has no effect on the direction of Korea Real i.e., Korea Real and Bridge Biotherapeutics go up and down completely randomly.

Pair Corralation between Korea Real and Bridge Biotherapeutics

Assuming the 90 days trading horizon Korea Real Estate is expected to under-perform the Bridge Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Korea Real Estate is 6.08 times less risky than Bridge Biotherapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Bridge Biotherapeutics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  824,437  in Bridge Biotherapeutics on September 24, 2024 and sell it today you would lose (430,437) from holding Bridge Biotherapeutics or give up 52.21% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Korea Real Estate  vs.  Bridge Biotherapeutics

 Performance 
       Timeline  
Korea Real Estate 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Korea Real Estate has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Korea Real is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Bridge Biotherapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Bridge Biotherapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Bridge Biotherapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Korea Real and Bridge Biotherapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Korea Real and Bridge Biotherapeutics

The main advantage of trading using opposite Korea Real and Bridge Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Korea Real position performs unexpectedly, Bridge Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bridge Biotherapeutics will offset losses from the drop in Bridge Biotherapeutics' long position.
The idea behind Korea Real Estate and Bridge Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity